Alphagalileo

titanium dioxide Journalism
2022 03-31 16:21
分享

Please register to view contact details

Please login or register to read this article.

LoginRegisterSign up for an AlphaGalileo Readers Account.Youll get three more stories free this month, then, if your university or employer has a Standard Level or Premium Level subscription once you have signed up youll get free access whilst that subscription is active.If you have a journalist or contributor login, please use it to gain full access to our service.If you wish to cancel at any time simply contact your bank to stop the standing order.This item is under embargo and is only visible to journalistsLocation:AddressOpening Hours:Ticket price:Broadcast content type:Broadcast starts:Broadcast duration:src=Publication title:Author:Publication type:Publication date:Number of pages:ISBN number:Price:Today, various treatment methods are available for cancer that can complement each other. Radiation therapy is frequently used, and can be combined with surgery and chemotherapy, for example. Although treatment with ionizing radiation has been used in medicine for more than 100 years, even modern oncology is sometimes not satisfied with its effectiveness. The reason: Malignant tumors are not always sensitive enough to radiation. If the sensitivity of the tumor cells could be increased, radiotherapy could be carried out more effectively and more gently, says Empa researcher Lukas Gerken.

In other words: A desired treatment outcome could be achieved with a lower dose of radiation than is currently the case, or particularly radiation-resistant tumors could finally become sensitive to radiation. The team led by Lukas Gerken and Inge Herrmann from the Particles-Biology Interactions Laboratory at Empa in St. Gallen and the Nanoparticle Systems Engineering Laboratory at ETH Zurich is therefore working with oncologists at the Cantonal Hospital in St. Gallen to find ways to sensitize tumor cells to radiation.

The researchers have set their sights on nanoparticles made of metal oxides that can act as so-called radiosensitizers. The team has now succeeded in producing these radiosensitizers in large quantities and analyzing their effect in more detail. The researchers recently published their results in the journal Chemistry of Materials.

In cancer research, studies are currently underway with various classes of substances to make the irradiation of tumors more effective. Exactly how nanoparticles made of gold or more exotic metal oxides such as hafnium dioxide work in this context is not yet fully understood. What is known, though, is that a complex reaction cascade exerts oxidative stress in cancer cells. In this way, the repair mechanisms of the malignant cells may be overwhelmed.

In order for the nanoparticles to be made available for clinical use, two hurdles had to be overcome: Production via conventional wet chemistry methods makes it difficult to produce quantities on an industrial scale, and there is a lack of comparative analyses on the efficacy of different substances.

Empa researcher Gerken has now succeeded in producing metal oxide radiosensitizers using a method that is ideally suited to industrial applications: He relied on flame synthesis to obtain top-quality oxides of hafnium, zirconium and titanium. Thanks to this production method, it is even possible depending on the production facility to synthesize several kilograms per day, explains Gerken. For the laboratory analyses at Empa, however, the scientist made do with just a few grams.

Once the nanoparticles were available in suitable quantities, Lukas Gerken was able to screen the gems in detail, for example using X-ray spectroscopy and electron microscopy. His verdict: We can produce sterile, high-quality metal oxide nanoparticles that appear harmless to healthy cells, the researcher explains. He proved this using cell cultures that he treated with different nanoparticle suspensions in the lab. The metal oxides accumulated in large quantities inside the cells. The front-runner was hafnium dioxide: Here, half a billion nanoparticles entered each individual cell without being toxic. Compared to the metal oxides, nanogold did much worse with the same particle size: About 10 to 30 times fewer gold particles made it into the cell.

As harmless as the substances initially are to healthy cells, they unfold their effects powerfully when used in radiation. The team was able to demonstrate this using cancer cell lines. If the cell cultures were treated with metal oxides and then bombarded with X-rays, the killing effect increased significantly. Hafnium dioxide turned out to be the most potent tool: Tumor cells treated with hafnium particles could be eliminated with less than half the radiation dose. This first comparative study also showed that hafnium dioxide is even four times more effective than nanogold and titanium dioxide. Healthy human cells (so-called fibroblasts), on the other hand, showed no negative radiation effects after nanoparticle treatment.

The results make Lukas Gerken confident: We will continue on this path to explore the nanoparticles mechanism of action and further optimize their efficiency. He hopes that his studies will thus advance the clinical application of nanoparticles in radiation therapy.

Scalable Synthesis of Ultrasmall Metal Oxide Radio-Enhancers Outperforming Gold

Lukas R.H. Gerken, Anna L. Neuer, Pascal M. Gschwend, Kerda Keevend, Alexander Gogos, Alexandre H.C. Anthis, Leonie Aengenheister, Sotiris E. Pratsinis, Ludwig Plasswilm, and Inge K. Herrmann; Chem. Mater. 2021, 33, 9, 30983112

Full size/a

Inside the cell: Nanoparticles of hafnium dioxide (yellow-green) accumulate in cancer cells and can cause cell damage after irradiation. (Electron microscopy, colored) Image: Empa/ ETH Zurich

Full size/a

Fire and Ice: Empa researcher Lukas Gerken produces nanoparticles for cancer therapy using flame synthesis. To make the tiny metal particles visible, the electron microscope is cooled to freezing temperatures with liquid nitrogen. Image: Empa

Keywords: Health, Medical, Science, Life Sciences, Applied science, Nanotechnology

The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.

Major work about Norwegian broadside ballads is published

New book explores musical inspiration of the railways

Learning Analytics: a Metacognitive Tool to Engage Students

Alliance of church and state in Russia fosters acceptance of Putins war

Cluster of Excellence Religion and Politics

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.

All of my work trips have been planned around stories that Ive found on this site.

The under embargo section allows us to plan ahead and the news releases enable us to find key experts.

Going through the tailored daily updates is the best way to start the day. Its such a critical service for me and many of my colleagues.

Koula Bouloukos, Senior manager, Editorial & Production Underknown

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UKs leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.

Peter Dunn, Director of Press and Media Relations at the University of Warwick

AlphaGalileo has helped us more than double our reach at . The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.